| Skin Squamous Cell Carcinoma studied in …STUDIED_INderived200 of 211show all (up to 200) |
|---|
| → studied in | NCT07144384early Phase 1 · completed Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339176Phase 1/Phase 2 · recruiting Intratumoral N17350 in Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05878288Phase 2 · active not recruiting Deep sequencIng in Cutaneous Squamous CEll caRciNomas · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014086Phase 1 · completed Intratumoral PH-762 for Cutaneous Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06585410Phase 3 · recruiting Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05358938early Phase 1 · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04166318Phase 2 · active not recruiting Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Anal Margin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04428671Phase 1 · active not recruiting Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05721755Phase 3 · active not recruiting Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233711Phase 3 · active not recruiting Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Anal Margin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809191NA · not yet recruiting Hair Regrowth Following Partial Thickness Removal of SSCIS · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602842Phase 1/Phase 2 · recruiting A Study of IDP-001 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02997553Phase 3 · completed Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Eyelid Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896839Phase 1/Phase 2 · recruiting Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990737Phase 2 · withdrawn Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07042295Phase 2 · suspended Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07115043Phase 1/Phase 2 · recruiting A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682831NA · recruiting Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746258NA · recruiting Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05888844Phase 2 · active not recruiting A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532279Phase 2 · recruiting Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859074Phase 1 · recruiting A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07600476Phase 1 · recruiting A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07426484Phase 4 · recruiting Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02955290Phase 1/Phase 2 · active not recruiting CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816332Phase 1 · active not recruiting Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580054Phase 2 · active not recruiting Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228442Phase 2 · recruiting L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684066not yet recruiting D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715734Phase 2 · not yet recruiting Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03565783Phase 2 · active not recruiting Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06288191Phase 2 · recruiting Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094685Phase 2 · recruiting Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975152Phase 1 · recruiting Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050162Phase 2/Phase 3 · suspended Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07100925Phase 1 · withdrawn A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04389112NA · completed Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616248Phase 1 · active not recruiting In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Scrotal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929028Phase 2 · active not recruiting Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Anal Margin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076760Phase 1 · recruiting MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06567314Phase 2 · recruiting Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04916002Phase 2 · terminated A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265285Phase 2 · recruiting Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05110781Phase 2 · terminated Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07286318early Phase 1 · recruiting A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944941Phase 2 · active not recruiting Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315701Phase 2 · active not recruiting A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06608511active not recruiting Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05910827Phase 1/Phase 2 · recruiting A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06998342Phase 2 · recruiting MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07606508recruiting Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment. · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03491176active not recruiting Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06782399early Phase 1 · enrolling by invitation Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05574101Phase 2 · active not recruiting A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06992427Phase 3 · recruiting High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455331Phase 2 · not yet recruiting Flash Radiotherapy for Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05747625Phase 1 · recruiting (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692556Phase 3 · recruiting Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04349436Phase 1/Phase 2 · active not recruiting Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03574792Phase 2 · completed Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377905Phase 1/Phase 2 · recruiting Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444815Phase 1 · recruiting A Study of VET3-TGI in Patients With Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05695222recruiting Cutaneous Squamous Cell Carcinoma Staging Study · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06327971active not recruiting Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06875609recruiting ctDNA in Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03969004Phase 3 · active not recruiting Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234113Phase 1 · terminated Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05724875NA · active not recruiting FLASH Radiotherapy for Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418724Phase 2 · not yet recruiting Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06008977NA · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04480645early Phase 1 · completed CivaDerm(TM) Surface Therapy Pilot Study · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06036836Phase 2 · completed Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04007744Phase 1 · active not recruiting Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223659Phase 2 · recruiting EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956795terminated Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06171750Phase 1 · recruiting Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06868433Phase 1 · recruiting TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288073Phase 2 · recruiting TIL Therapy in cSCC and MCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07402616NA · recruiting Ex Vivo Cutaneous SCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07394244Phase 2 · not yet recruiting Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04913220Phase 1/Phase 2 · terminated A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082534Phase 2 · completed Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05085496Phase 1 · recruiting Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04163952Phase 1 · terminated Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07361666not yet recruiting Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03889912Phase 1 · completed Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347392enrolling by invitation The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark. · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482880completed Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04154943Phase 2 · completed Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06659146NA · recruiting Thermotherapy in Addition to SOC Palliative Radiotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06606028recruiting Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132191approved for marketing Expanded Access Use of Cemiplimab in Patients With Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04454489Phase 2 · completed Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256381Phase 2 · terminated A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03901573Phase 1/Phase 2 · terminated High-Risk Skin Cancers With Atezolizumab Plus NT-I7 · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565417Phase 1/Phase 2 · active not recruiting Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03836105completed CemiplimAb Survivorship Epidemiology · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06664151early Phase 1 · recruiting A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536257recruiting Personalised Immunotherapy Platform · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04892849recruiting Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064330recruiting Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab. · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954226Phase 1 · completed Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04429542Phase 1 · recruiting Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04620200Phase 2 · completed Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242199Phase 1 · completed Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286294Phase 2 · active not recruiting Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03737721Phase 2 · terminated The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305795Phase 1/Phase 2 · active not recruiting An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384053NA · recruiting Skin Cancer and Hyperthermia and Radiotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05108090NA · recruiting Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06823479Phase 2 · recruiting Towards Cure Via Only Ultra-short ICB in CSCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760498Phase 2 · completed Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03108131Phase 2 · completed Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03524326Phase 1 · completed Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329221Phase 2 · withdrawn Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04642287Phase 2 · withdrawn Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644079Phase 2 · withdrawn Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301011Phase 1 · terminated Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339062Phase 1/Phase 2 · completed Cemiplimab in AlloSCT/SOT Recipients With CSCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014619active not recruiting Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014697completed OCT and Invasion in Cutaneous Skin Lesions · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020612completed Interobserver Variability Desmoplasia · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06046625active not recruiting Needs and Preferences of Patients With Head-neck Cutaneous SCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03894618Phase 1 · completed SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06879964recruiting Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04632433Phase 2 · active not recruiting Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05741073recruiting Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502888Phase 1 · terminated Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212404Phase 1 · active not recruiting Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04710498Phase 2 · completed Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04050436Phase 2 · active not recruiting Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04807777Phase 2 · terminated Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870840Phase 1 · completed Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620134Phase 1/Phase 2 · active not recruiting Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06610071Phase 1 · not yet recruiting NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04160065Phase 1 · completed Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370861terminated How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06577311Phase 2 · unknown Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04853602available IFx-Hu2.0 Expanded Access Program · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536946unknown B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925713Phase 1 · completed IFx-Hu2.0 for the Treatment of Patients With Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384820Phase 2 · withdrawn Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084845Phase 2 · withdrawn Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02964559Phase 2 · completed Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04204837Phase 2 · recruiting Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05412875NA · withdrawn Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06342297NA · unknown Dermatoscopy Guided Resection for Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03590054Phase 1 · completed Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324608NA · completed Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05490485Phase 2 · unknown Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04362722Phase 2 · unknown Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05845632unknown Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05729139Phase 1 · withdrawn Cemiplimab/Peg-Interferon-α in Advanced CSCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886140NA · unknown Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05493826completed Real World Study on the Use of Cemiplimab in Adult Patients in UK · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04252612early Phase 1 · withdrawn Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03982212Phase 1 · unknown A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05220748Phase 1 · withdrawn RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04611321Phase 1/Phase 2 · terminated Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775525Phase 1 · unknown Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242173Phase 2 · terminated Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02218164Phase 2 · completed Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985825Phase 2 · withdrawn Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025813Phase 2 · recruiting Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04596033Phase 1 · terminated TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05238363Phase 2 · unknown The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04664582NA · unknown Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05246228unknown Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03291002Phase 1 · unknown Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03773744Phase 1 · withdrawn MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03353077NA · completed Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT) · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02347813Phase 2 · completed Preventing Squamous Cell Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01198028Phase 2 · completed Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03834233Phase 2 · unknown Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126555Phase 2 · completed Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03492489no longer available Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01017185Phase 1 · completed Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03822988unknown ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS · condition mapped ONTOLOGY_EXACT · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01764607Phase 2 · terminated Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03621462NA · unknown Elucid Labs AIDA™ - Labelled Image Acquisition Protocol · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823679Phase 2 · terminated Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01984892Phase 2 · terminated Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) · condition mapped ALIAS · 211 trials mapped (106 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |